1. Home
  2. VVOS vs EDSA Comparison

VVOS vs EDSA Comparison

Compare VVOS & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • EDSA
  • Stock Information
  • Founded
  • VVOS 2016
  • EDSA 2015
  • Country
  • VVOS United States
  • EDSA Canada
  • Employees
  • VVOS N/A
  • EDSA N/A
  • Industry
  • VVOS Medical Specialities
  • EDSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • VVOS Health Care
  • EDSA Health Care
  • Exchange
  • VVOS Nasdaq
  • EDSA Nasdaq
  • Market Cap
  • VVOS 14.8M
  • EDSA 13.8M
  • IPO Year
  • VVOS 2020
  • EDSA N/A
  • Fundamental
  • Price
  • VVOS $3.28
  • EDSA $2.05
  • Analyst Decision
  • VVOS Strong Buy
  • EDSA Strong Buy
  • Analyst Count
  • VVOS 2
  • EDSA 2
  • Target Price
  • VVOS $6.10
  • EDSA $13.00
  • AVG Volume (30 Days)
  • VVOS 236.5K
  • EDSA 33.4K
  • Earning Date
  • VVOS 08-13-2025
  • EDSA 08-08-2025
  • Dividend Yield
  • VVOS N/A
  • EDSA N/A
  • EPS Growth
  • VVOS N/A
  • EDSA N/A
  • EPS
  • VVOS N/A
  • EDSA N/A
  • Revenue
  • VVOS $14,628,000.00
  • EDSA N/A
  • Revenue This Year
  • VVOS $17.40
  • EDSA N/A
  • Revenue Next Year
  • VVOS $10.78
  • EDSA N/A
  • P/E Ratio
  • VVOS N/A
  • EDSA N/A
  • Revenue Growth
  • VVOS 9.47
  • EDSA N/A
  • 52 Week Low
  • VVOS $1.97
  • EDSA $1.55
  • 52 Week High
  • VVOS $6.28
  • EDSA $5.59
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 70.72
  • EDSA 52.89
  • Support Level
  • VVOS $2.03
  • EDSA $1.91
  • Resistance Level
  • VVOS $3.91
  • EDSA $2.14
  • Average True Range (ATR)
  • VVOS 0.26
  • EDSA 0.12
  • MACD
  • VVOS 0.13
  • EDSA 0.02
  • Stochastic Oscillator
  • VVOS 66.49
  • EDSA 64.52

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: